PubMed · 1999 · 218 citations · 11 references
MedicineGeneticsOncologyGene ExpressionMetastasisTumor ProgressionCancer GenomicsMalignant NeoplasmsMatrix Metalloproteinase GeneticsMolecular Tumor ProfilingOvarian CancerInsertion-deletion Polymorphism MarkersInsertion-deletion VariantsInsertion-deletion VariationMatrix Metalloproteinase 1 GeneticsMatrix Metalloproteinase Gene ExpressionMatrix Metalloproteinase Gene FamilyMatrix Metalloproteinase Gene PolymorphismsMatrix Metalloproteinase Promoter Polymorphisms
Matrix metalloproteinases (MMPs), a family of closely related enzymes that degrade the extracellular matrix, are likely to be involved in invasion and metastasis of tumor cells. A guanine (G) insertion/deletion polymorphism within the promoter region of MMP-1 influences the transcription of this gene; i.e., the 2G (insertion-type) promoter possesses greater transcriptional activity than the 1G (deletion-type) promoter. To investigate whether this feature contributes to cancer development and/or progression, we genotyped 163 ovarian cancer patients for the polymorphism and then analyzed levels of expression of the MMP-1 gene in their tumors. The proportion of patients who were either heterozygotes or homozygotes for the 2G allele was significantly higher than that observed among 150 individuals without cancer (P = 0.028). Moreover, the levels of MMP-1 expression in cancer tissues among the patients carrying 2G alleles were elevated significantly in comparison with 1G homozygotes (P = 0.0038). By stimulating degradation of extracellular matrix, an excess of MMP-1 production may enhance development and/or rapid progression of ovarian cancers.
11
Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer
Graeme I. Murray, Margaret E. Duncan, Pauline O'Neil et al. · Nature Medicine · 1996 · 447 citations
Medicine, Cancer Biology, Oncology +11
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
B Davies, Jonathan Waxman, Harpreet Wasan et al. · PubMed · 1993 · 427 citations
Ian R. Hart, Ashish Saini · The Lancet · 1992 · 313 citations
Medicine, Cancer Biology, Oncology +12